4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-25-035174
Options or other derivatives
- Director acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| CANNON MICHAEL D Director | 2025-11-12 | Grant or award · Stock Options (right to buy) | +150,000 | 165,336 | D | ||
Loading xslF345X05/rdgdoc.xml…